Pharma Industry Reports
European Pharmaceutical Review have partnered with Datamonitor Group to present a series of reports covering every aspect of the pharmaceutical industry.
The “Patent Cliff”: How Pfizer has responded to the loss of its best-selling drug
The global pharmaceuticals market was worth $733bn in 2010. With the patents of many of the world’s best-selling drugs expiring, the market is currently in the middle of a “patent cliff”. This Case Study looks at the various routes companies are taking in order to minimize the adverse effects caused by this “patent cliff”.
OTC Pharmaceuticals: Global Industry Almanac 2011
OTC Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Ultimate go-to guides for reliable insights on the consumer industry…
MarketLine’s Industry Profiles will help you to form a clear picture of individual sectors, including who is operating within them and how they are performing.
Concise and accurate, Industry Profiles are presented within the globally recognized Porter’s Five Forces analysis framework to help you understand and apply key insights in minutes.
They are the ideal starting point for gaining a top-level understanding of the pharmaceutical and healthcare sectors – across the globe.
Each Industry Profile includes:
- Forecasts for the market
- Market value and volume data
- Industry segmentation
- Macroeconomic analysis
- Competitor analysis
- Leading company information
Johnson & Johnson Case Study: Remicade, a Biotech Blockbuster
Remicade is a drug used in treating a variety of immune system diseases, and its active ingredient is produced through biotechnology. Johnson & Johnson reported Remicade sales of $4.6bn in 2010, and the drug is the best-selling “biologic” in the world. This case study examines its long journey from an academic research laboratory to a leading position in the pharmaceutical market.
Product Insight: Country and Industry Analysis
MarketLine’s Country and Industry Analysis Profiles provide a quick and convenient access point to information on a wide breadth of industries and the countries in which they operate – presenting a holistic overview of individual sectors and their geographic context…
Our Country and Industry Analysis Profiles Include:
- Forecasts for the market
- Market value and volume information
- Geographic and category segmentation
- Porter’s Five Forces industry analysis
- PESTLE country analysis.
Biotechnology: Global Industry Guide
Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Product Insight: Company Profiles
European Pharmaceutical Review in association with Datamonitor Group is pleased to introduce you to our array of company profiles available on our RESEARCH STORE – your one stop to all research needs!
Browse and search for the latest merger and acquisition activity, lists of company products and services, and key competitor information for our entire portfolio of companies now…
Our Company Profiles:
- Provide all the crucial company information required for business and competitor intelligence needs.
- Contain a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Pharmaceutical Key Trends 2011: Socio-Demographic and Economic Overview
This report focuses on the socio-demographic and economic trends that are shaping the healthcare industry, and their impact on healthcare payers and the pharmaceutical industry, both directly and indirectly.
United Kingdom: Pharmaceuticals Industry Guide 2011
United Kingdom: Pharmaceuticals Industry Guide is an essential resource for top-level data & analysis covering the United Kingdom Pharmaceuticals industry. It includes data on market size & segmentation, textual analysis of the key trends & competitive landscape. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals & Pharmaceuticals.
Case Study: Personalized Cancer Therapy – The era of biomarker identification and companion diagnostic co-development
The treatment of cancer has seen a dramatic shift with the addition of molecular targeted therapies. The mixed and unpredictable responses to these targeted therapies are driving the pharmaceutical industry to search for disease and patient characteristics which confer the best response rates. Identification of biomarkers and companion diagnostics will pave the way for personalized cancer therapy.
Future Directions in Regenerative Medicine
This report covers the development of therapies to replace human cells or promote their regeneration: including cell therapies, tissue engineering, drugs, and medical devices. Each company profiled has at least one project in preclinical or Phase I study. Many also have later stage or launched products, which are covered briefly to illustrate the potential of the next generation of candidates.
The Drug Discovery Outsourcing Market
This report investigates current trends and opportunities affecting decisions on whether or not to outsource drug discovery. Outsourcing to low cost offshore destinations such as China and India are examined in detail. The report also covers a variety of strategic collaborations, academic partnerships and outsourcing opportunities along with case studies.